Cardionomic Inc.

Israeli acute heart failure (HF) therapy firm Magenta Medical Ltd. has bulked up its coffers with an additional $15m, following a Series B financing that brought in new investors from Japan and th

The US neuromodulation technology market, worth $2.3 billion in 2014, is poised to grow 46% over the next five years, reaching $3.3 billion in 2019, and potentially rivaling markets like that for coro

Device Transactions Device companies raised a total of $1.2 billion in financing in the fourth quarter, a 16% decrease from Q3's $1.4 billion. Q4 turned out to have the second-lowest financing aggrega

2015 was a truly remarkable year for early-stage venture capital investment in the life science sector. The total amount of money raised in A rounds by life science companies (biopharma, pharma, medte